- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Anti-GFRAL/ C6orf144/ GRAL monoclonal antibody
Anti-GFRAL/ C6orf144/ GRAL antibody for FACS & in-vivo assay
Go to GFRAL/GFRAL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
MSDSProduct information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T37012-Ab-1/ GM-Tg-hg-T37012-Ab-2 | Anti-Human GFRAL monoclonal antibody | Human |
| GM-Tg-rg-T37012-Ab-1/ GM-Tg-rg-T37012-Ab-2 | Anti-Rat GFRAL monoclonal antibody | Rat |
| GM-Tg-mg-T37012-Ab-1/ GM-Tg-mg-T37012-Ab-2 | Anti-Mouse GFRAL monoclonal antibody | Mouse |
| GM-Tg-cynog-T37012-Ab-1/ GM-Tg-cynog-T37012-Ab-2 | Anti-Cynomolgus/ Rhesus macaque GFRAL monoclonal antibody | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T37012-Ab-1/ GM-Tg-felg-T37012-Ab-2 | Anti-Feline GFRAL monoclonal antibody | Feline |
| GM-Tg-cang-T37012-Ab-1/ GM-Tg-cang-T37012-Ab-2 | Anti-Canine GFRAL monoclonal antibody | Canine |
| GM-Tg-bovg-T37012-Ab-1/ GM-Tg-bovg-T37012-Ab-2 | Anti-Bovine GFRAL monoclonal antibody | Bovine |
| GM-Tg-equg-T37012-Ab-1/ GM-Tg-equg-T37012-Ab-2 | Anti-Equine GFRAL monoclonal antibody | Equine |
Size： 1mg | 10mg | 100mg
Product Description
| Catalog No. | GM-Tg-hg-T37012-Ab-1/ GM-Tg-hg-T37012-Ab-2; GM-Tg-rg-T37012-Ab-1/ GM-Tg-rg-T37012-Ab-2; GM-Tg-mg-T37012-Ab-1/ GM-Tg-mg-T37012-Ab-2; GM-Tg-cynog-T37012-Ab-1/ GM-Tg-cynog-T37012-Ab-2; GM-Tg-felg-T37012-Ab-1/ GM-Tg-felg-T37012-Ab-2; GM-Tg-cang-T37012-Ab-1/ GM-Tg-cang-T37012-Ab-2; GM-Tg-bovg-T37012-Ab-1/ GM-Tg-bovg-T37012-Ab-2; GM-Tg-equg-T37012-Ab-1/ GM-Tg-equg-T37012-Ab-2 |
| Products Name | Anti-GFRAL monoclonal antibody |
| Format | mab |
| Target Name | GFRAL |
| Protein Sub-location | Transmembrane Protein |
| Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody |
| Derivation (species) | Mouse |
| CH1+2+3 Isotype (Receptor identification) | IgG |
| Type of Light Chain (VD-LC) | N/A |
| Expression platform | Mammalian Expression |
| Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
| Tag | Fc |
| Products description | Pre-made anti-GFRAL benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
| Target Antigen | Products Developing | Multi-species GFRAL/ C6orf144/ GRAL VLP (virus-like particle) (Products Developing) |
| Cytokine | GM-Tg-g-T37012-Ag-1 | GDNF family receptor alpha like (GFRAL) protein |
| ORF Viral Vector | vGMLP001654 | human GFRAL Lentivirus particle |
| ORF Viral Vector | pGMLP001654 | human GFRAL Lentivirus plasmid |
| ORF Viral Vector | pGMLPm004307 | mouse Gfral Lentivirus plasmid |
| ORF Viral Vector | vGMLPm004307 | mouse Gfral Lentivirus particle |
Target information
| Target ID | GM-T37012 |
| Target Name | GFRAL |
| Gene ID | 389400,404194,501023,714935,481851,101097066,531956,100069686 |
| Gene Symbol and Synonyms | bA360D14.1,C6orf144,GFRAL,GRAL,RGD1565220,UNQ9356 |
| Uniprot Accession | Q6UXV0,D3ZB94 |
| Uniprot Entry Name | GFRAL_HUMAN,GFRAL_RAT |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, Cytokine Target |
| Disease | N/A |
| Gene Ensembl | ENSG00000187871 |
| Target Classification | N/A |
The target: GFRAL, gene name: GFRAL, also named as C6orf144, GRAL, UNQ9356, bA360D14.1. Enables glial cell-derived neurotrophic factor receptor activity and receptor tyrosine kinase binding activity. Involved in glial cell-derived neurotrophic factor receptor signaling pathway; positive regulation of MAPK cascade; and positive regulation of protein kinase B signaling. Located in external side of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.
Facebook
LinkedIn
Twitter
